Medical research offers the best opportunity to learn, transform and improve the lives of Australians affected by epilepsy.
Even though epilepsy affects more people than multiple sclerosis, cerebral palsy, muscular dystrophy and Parkinson’s combined, it is one of the most underfunded and under-researched conditions in this country and across the world. We need your help to change this situation and support us in investing in further research into diagnosing, treating and ultimately curing epilepsy.
Epilepsy Action Australia is committed to supporting research that show promising beneficial results for people with epilepsy and we are seeking to expand the number of projects we support in collaboration with leading medical and academic institutions.
In addition, we will continue to develop evidence-based services that target identified needs of those with epilepsy; and articulate to funding providers, such as government and corporations, tangible outcomes, particularly those of national importance.
But we can’t do any of this without your help!
Please help us invest in research that will have a life-impacting change for people with epilepsy by becoming a Research Advocate today
Improve Lives: Become a Research Advocate
By providing a regular monthly donation, our valued Research Advocates truly make a difference to people with epilepsy. All donations are invested directly in support of research projects and initiatives that will ultimately help people with epilepsy live better lives.
Without the vital assistance of our very special Research Advocates we would not be able to continue our collaborative work into such important areas as medicinal cannabis trials to help control seizures in children, wearable technologies and medication use in pregnancy (see story below).
The benefits of new knowledge created by this research will make the future so much brighter for people affected by epilepsy.
Please help us invest in research that will have a life-impacting change for people with epilepsy by becoming a Research Advocate today!
Ensuring the safety of pregnant women
The APR has published its significant findings, which include:
- over 95 percent of pregnant women with epilepsy deliver a healthy baby, even under medical treatment
- if a woman is seizure-free for at least 12 months prior to pregnancy, her chance of having a seizure during the pregnancy and delivery is significantly reduced
- avoid sodium valproate (Epilim) if equally effective AEDs are available
- sodium valproate (Epilim) in doses above 800mg per day is associated with a greater risk of foetal abnormality than other AEDs, however, sodium valproate in lower doses may be more effective in preventing seizures in some forms of epilepsy.
Epilepsy Action Australia is proud to be involved in such crucial medical research that benefits women with epilepsy in Australia and around the world. It provides new information that helps mothers make important decisions about managing their epilepsy during pregnancy, leading to better outcomes for both mother and baby.